ReviewFrontiers in molecular biosciences2025
ARF: the most misunderstood GTPase I ever knew - why study ARF GAPs.
Review in Frontiers in molecular biosciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
ADP-ribosylation factors (ARFs) are GTP-binding proteins that were discovered in the early 1980s, shortly after heterotrimeric GTP-binding proteins (G proteins) and nearly simultaneously with RAS. G proteins formed the basis for the signaling paradigm that has been broadly applied to GTPases, including both RAS and ARF. In this paradigm, GTP-binding proteins act as switches. When converted from the GDP-bound form to the GTP-bound form, GTPases bind effector proteins to transduce a signal. This paradigm is consistent, at least in part, with RAS function as RAS•GTP activates effectors to drive cellular responses such as proliferation. ARF, on the other hand, functions outside this paradigm, at least in its first discovered physiological role: regulation of membrane traffic. Nevertheless, ARFs are often generalized as "on" and "off" switches controlling signaling pathways. In this study, we (i) briefly describe the history of the discoveries of three families of GTPases to provide an understanding of the genesis of the G-protein signaling model, (ii) enumerate some key differences between ARFs, RAS, and G proteins (which better fit the paradigm of molecular switches), and (iii) describe an alternate model for ARFs, in which their cycling between GTP binding and hydrolysis mediates cellular activities, rather than ARFs acting as mediators in a signaling cascade. Furthermore, we highlight the key role of GTPase-activating proteins (GAPs) as integral to ARF function.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.